semaglutide phase 3 Novo Nordisk Announces Positive Results for Oral Pill in Adolescents with Type 2 Diabetes, ETPharma Phase 3 ESSENCE trial: Semaglutide

Saran A, Kumari P, Arya K, Sharma S, Paliwal S (2024) Key modifiers of glucose metabolism associated diseases (GMADs): a mini review

MedeAnalytics receives clinical data information for approximately 380,000 beneficiaries, representing more than half of the agency's 675,000 beneficiaries

IDR-containing proteins, such as FUS, EWS, and TAF15, accumulate through LLPS at sites of DNA damage in a PAR-dependent manner 130

In contrast, another study showed that cardiomyocyte-specific glucocorticoid receptor ablation in mice delayed postnatal cardiomyocyte cell cycle exit, hypertrophic growth, and cytoarchitectural maturation 57

What are Its Properties, And What is Worth Knowing About It